Search
New study discovers inhibitors of protein linked to the devastating childhood brain cancer DIPG
- OPACC
- Oct 17, 2018
- 1 min read
Scientists at The Institute of Cancer Research, London in collaboration with a team at the Structural Genomics Consortium in Oxford (SGC) have created a new series of compound that could form the basis for drugs that target the devastating childhood brain cancer diffuse intrinsic pontine glioma, or DIPG.
Recent Posts
See AllAmong pediatric patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT), using...
Neuroblastomas are the most common cancer in infants, with about 700–800 diagnoses per year in the US, according to the American Cancer...
Childhood cancer survivors are more likely than the general population to develop chronic health conditions and die before reaching 65...